WebApr 11, 2024 · In this study, we evaluated the efficacy and safety of intrathecal chemotherapy (IC)-based regimens in patients with refractory LM. Methods: We retrospectively enrolled NSCLC patients with confirmed LM who received IC and systemic therapy at the Second Affiliated Hospital of Nanchang University from December 2024 to … WebApr 11, 2024 · MOHRBACHER: Based on the NCCN [National Comprehensive Cancer Network] classic pathways for patients with relapsed or refractory DLBCL and its cousins, we have the DHAP [dexamethasone, cytarabine, and platinum (cisplatin)] combination. 1 Virtually every [combination] has rituximab: R-DHAP or R-ICE [rituximab, ifosfamide, …
What is Refractory Cancer? - News-Medical.net
WebJul 8, 2024 · Patients with metastatic cancer refractory to standard systemic therapies have a poor prognosis and few therapeutic options. Radiotherapy can shape the tumor microenvironment (TME) by inducing immunogenic cell death and promoting tumor recognition by natural killer cells and T lymphocytes. Granulocyte macrophage-colony … WebPatients who have not achieved complete remission after two cycles of induction chemotherapy are usually diagnosed as having "refractory AML." Relapsed AML: Some patients reach remission and then have a … netflix price change history
Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus ...
WebMay 17, 2024 · Aggressive B-cell lymphomas that are primary refractory to, or relapse after, frontline chemoimmunotherapy have a low cure rate with conventional therapies. Although high-dose chemotherapy remains the standard of care at first relapse for sufficiently young and fit patients, fewer than one-quarter of patients with relapsed/refractory disease are … WebDespite chemotherapy innovations, prognosis of patients with chemotherapy-refractory or -unfit multiple metastases (CRMM/CUMM) remains poor. In this prospective study, the … WebApr 5, 2024 · The goal of therapy in relapsed and/or refractory (R/R) ALL is to induce a subsequent remission and then to consolidate that complete response (CR) with an allogeneic hematopoietic cell transplant (allo-HCT) on the basis of a significant survival benefit seen with an allo-HCT. 5 To achieve a CR after relapse and proceed with allo … itunes wav変換できない